Anxiety & Stress

Anxiety and stress exist on a spectrum—from transient, situational stress responses to chronic, impairing anxiety disorders such as generalized anxiety disorder (GAD) and panic disorder. A balanced, integrative view recognizes that conventional Western medicine offers well-validated diagnoses and first-line therapies with strong evidence for reducing symptoms and restoring function, while Eastern and traditional modalities contribute effective mind–body practices and, in some cases, promising herbal supports. The best outcomes often come from combining structured, guideline-based treatments with skills that improve stress resilience and nervous-system regulation. In Western medicine, clinicians use DSM-5-TR criteria to differentiate everyday stress reactions from anxiety disorders. GAD is defined by excessive worry occurring more days than not for at least six months, plus associated symptoms (restlessness, fatigue, muscle tension, irritability, sleep disturbance) and functional impairment. Panic disorder involves recurrent, unexpected panic attacks and persistent concern or behavior change related to the attacks. Validated screeners (e.g., GAD-7, Panic Disorder Severity Scale) help gauge severity and track progress. First-line treatments include cognitive behavioral therapy (CBT)—particularly exposure-based interventions for panic and avoidance—and antidepressant medications, primarily SSRIs and SNRIs. These approaches have robust evidence bases from randomized trials and practice guidelines. Adjuncts such as buspirone, hydroxyzine, and beta-blockers for performance anxiety are selectively used. Benzodiazepines can rapidly reduce acute anxiety but carry dependence, tolerance, and cognitive side-effect risks; most guidelines recommend short-term, cautious use if at all. Beyond symptom suppression, Western psychotherapies aim to change anxious thinking and avoidance patterns. CBT and exposure therapy reliably reduce symptoms across anxiety disorders, with effect-sz

Mental Health Updated March 2, 2026

This content is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare provider before starting, stopping, or changing any supplement or medication regimen.

Western Medicine

Diagnosis

DSM-5-TR criteria distinguish normal stress from disorders such as GAD (excessive, hard-to-control worry ≥6 months with somatic/cognitive symptoms) and panic disorder (recurrent unexpected panic attacks plus persistent concern/behavioral change). Clinicians assess impairment, rule out medical/substance causes, and often use screeners (GAD-7, Panic Disorder Severity Scale).

Treatments

Psychoeducation and monitoring (e.g., GAD-7)
Cognitive Behavioral Therapy (CBT) for anxiety
Exposure-based therapy (including interoceptive exposure for panic)
Acceptance and Commitment Therapy (ACT) or mindfulness-informed CBT
SSRIs or SNRIs as first-line pharmacotherapy
Buspirone or hydroxyzine as non-benzodiazepine options
Beta-blockers for performance anxiety (situational)
Pregabalin (used in some regions as second-line for GAD)
Short-term benzodiazepines for severe acute symptoms (with caution)
Lifestyle supports (sleep, exercise, reduced substances)
Emerging: ketamine (off-label), psychedelic-assisted therapy (investigational)

Medications

SSRIs: sertraline, escitalopram, paroxetine, fluoxetine
SNRIs: venlafaxine, duloxetine
Buspirone
Hydroxyzine
Beta-blockers: propranolol (performance anxiety)
Benzodiazepines: clonazepam, lorazepam, alprazolam (short-term/cautious)
Pregabalin (region-specific)
Emerging: ketamine/esketamine (off-label for anxiety)

Limitations

Partial or non-response is common; medications can cause side effects (e.g., GI upset, sexual dysfunction, activation). Benzodiazepines carry risks of tolerance, dependence, withdrawal, and cognitive impairment. Access to skilled CBT/exposure therapy can be limited; relapse may occur without ongoing skills practice. Emerging treatments like ketamine and psychedelic-assisted therapy show promise but remain off-label or investigational for anxiety and require specialized settings and safeguards.

Evidence: Strong Evidence

Sources

American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, 5th ed., Text Revision (DSM-5-TR). 2022.
NICE. Generalised anxiety disorder and panic disorder in adults: management (CG113). 2011; updated 2018. https://www.nice.org.uk/guidance/cg113
Bandelow B et al. WFSBP guidelines for the pharmacological treatment of anxiety, OCD, and PTSD (update). World J Biol Psychiatry. 2023.
Hofmann SG et al. The efficacy of cognitive behavioral therapy: A review of meta-analyses. Cognit Ther Res. 2012;36:427-440.
Norton PJ, Price EC. A meta-analytic review of adult CBT for anxiety disorders. J Nerv Ment Dis. 2007;195(6):521-531.
Glue P et al. Ketamine for refractory generalized and social anxiety: randomized, placebo-controlled crossover trial. J Psychopharmacol. 2018;32(12):1296-1302.
Ross S et al. Rapid and sustained symptom reduction following psilocybin for anxiety and depression in life-threatening cancer: RCT. J Psychopharmacol. 2016;30(12):1165-1180.
Lader M. Benzodiazepines revisited—will we ever learn? Addiction. 2011;106(12):2086-2109.

Eastern & Traditional Medicine

Meditation and Mindfulness

Mindfulness-based programs train nonjudgmental awareness of thoughts, sensations, and emotions, reducing cognitive reactivity and autonomic arousal. Regular practice builds attentional control and stress resilience and complements CBT by reinforcing exposure and acceptance skills.

Techniques

Mindfulness-Based Stress Reduction (MBSR)
Mindfulness-Based Cognitive Therapy (MBCT)
Sitting meditation, body scan, mindful movement

MBSR/MBCT-certified instructor Psychologist or therapist with mindfulness training

Evidence: Strong Evidence

Yoga and Breathwork (Pranayama)

Yoga integrates movement, breath regulation, and attentional focus to downregulate the stress response and improve interoception. Evidence supports reductions in state and trait anxiety and physiologic stress markers; pranayama and slow, diaphragmatic breathing enhance vagal tone and emotional regulation.

Techniques

Yoga-based interventions (e.g., Hatha, Iyengar)
Diaphragmatic breathing, 4-6 breaths/min
Alternate-nostril breathing (nadi shodhana)
Sudarshan Kriya–style cyclical breathing

Yoga therapist (C-IAYT) Experienced yoga instructor Physical therapist with yoga training

Evidence: Strong Evidence

Adaptogenic Herbs (Ayurveda/Herbalism)

Certain adaptogens may modulate the hypothalamic–pituitary–adrenal (HPA) axis and GABAergic/serotonergic systems, potentially improving perceived stress and mild anxiety. Evidence is most consistent for ashwagandha; rhodiola and holy basil have smaller or lower-quality trials. Use cautiously due to quality variability and interaction risks.

Techniques

Ashwagandha (Withania somnifera) root extracts
Rhodiola rosea standardized extracts (e.g., SHR-5)
Holy basil/Tulsi (Ocimum sanctum) extracts

Ayurvedic practitioner Naturopathic doctor Integrative/functional medicine clinician

Evidence: Emerging Research

Traditional Chinese Medicine (TCM): Acupuncture and Herbal Formulas

TCM conceptualizes anxiety as disharmony among organ-meridian systems (e.g., Heart, Liver). Acupuncture aims to regulate qi and autonomic balance; some studies suggest benefits for anxiety symptoms and insomnia, though evidence quality is mixed. Herbal formulas (e.g., Xiao Yao San, Suan Zao Ren Tang) are tailored to patterns and may help sleep and somatic tension; overall evidence remains limited and heterogeneous.

Techniques

Manual acupuncture and electroacupuncture
Pattern-based herbal formulas (e.g., Xiao Yao San; Suan Zao Ren Tang)
Adjunctive qigong or tai chi

Licensed acupuncturist (L.Ac.) TCM herbalist Integrative physician with TCM training

Evidence: Emerging Research

Sources

Goyal M et al. Meditation programs for psychological stress and well-being: systematic review and meta-analysis. JAMA Intern Med. 2014;174(3):357-368.
Khoury B et al. Mindfulness-based therapy: A comprehensive meta-analysis. Clin Psychol Rev. 2013;33(6):763-771.
Goldberg SB et al. Mindfulness-based interventions for psychiatric disorders: a meta-analysis. Clin Psychol Rev. 2018;59:52-60.
Cramer H et al. Yoga for anxiety: a systematic review and meta-analysis of RCTs. Depress Anxiety. 2018;35(9):830-843.
Vollbehr NK et al. Yoga as a treatment for anxiety disorders: systematic review and meta-analysis. J Anxiety Disord. 2018;61:201-214.
Zaccaro A et al. How breath-control can enhance psychophysiological well-being: systematic review. Front Hum Neurosci. 2018;12:353.
Pascoe MC et al. Yoga, mindfulness-based stress reduction and stress-related physiological measures: meta-analysis. Psychoneuroendocrinology. 2017;86:152-168.
Chandrasekhar K et al. Ashwagandha root extract for stress/anxiety: randomized, double-blind, placebo-controlled. Indian J Psychol Med. 2012;34(3):255-262.
Lopresti AL et al. Efficacy and safety of ashwagandha in adults with stress and anxiety: randomized, double-blind, placebo-controlled. Medicine (Baltimore). 2019;98:e17186.
Ng QX et al. Ashwagandha for anxiety and stress: systematic review and meta-analysis. J Altern Complement Med. 2020;26(11):1061-1067.
Darbinyan V et al. Rhodiola rosea in stress-related fatigue with anxiety symptoms: RCT. Phytomedicine. 2007;14:87-95.
Cohen MM. Tulsi—Ocimum sanctum: a herb for all reasons. J Ayurveda Integr Med. 2014;5(4):251-259.
Pilkington K et al. Acupuncture for anxiety and anxiety disorders: systematic review. Acupunct Med. 2007;25(1-2):1-10.
Amorim D et al. Acupuncture and electroacupuncture for anxiety disorders: systematic review. Complement Ther Clin Pract. 2018;33:201-207.
Wang YQ et al. Suanzaoren decoction for primary insomnia: meta-analysis of RCTs. Sleep Med. 2020;67:251-260.
Zhang ZJ et al. Xiao Yao San for depressive/anxiety symptoms: systematic review. J Altern Complement Med. 2012;18(12):1108-1120.

Integrative Perspective

For mild to moderate anxiety or high stress, start with evidence-based psychotherapy (CBT/exposure or ACT) and add meditation/mindfulness and yoga/pranayama—both have strong evidence for reducing anxiety and autonomic arousal and can enhance CBT skill generalization. For moderate to severe or function-impairing anxiety, SSRIs/SNRIs or guideline-based pharmacotherapy plus CBT remain first-line; mindfulness and yoga remain valuable adjuncts for symptom control, sleep, and relapse prevention. Consider acupuncture as an adjunct particularly for somatic tension and insomnia, acknowledging mixed evidence. If exploring adaptogens (e.g., ashwagandha), involve a qualified clinician to check for interactions (thyroid disease, sedatives, SSRIs/SNRIs, liver issues) and product quality; avoid in pregnancy unless advised by a clinician. Limit or avoid benzodiazepines when possible; if used, restrict to short-term, monitored indications. Across all approaches, anchor care in sleep hygiene, regular aerobic/resistance exercise, reduced stimulants/alcohol/cannabis, and social support. Coordinate care among licensed professionals to ensure safety and avoid duplicative or interacting treatments.

Sources

American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, 5th ed., Text Revision (DSM-5-TR). 2022.
NICE. Generalised anxiety disorder and panic disorder in adults: management (CG113). 2011; updated 2018. https://www.nice.org.uk/guidance/cg113
Hofmann SG et al. The efficacy of cognitive behavioral therapy: A review of meta-analyses. Cognit Ther Res. 2012;36:427-440.
Norton PJ, Price EC. A meta-analytic review of adult CBT for anxiety disorders. J Nerv Ment Dis. 2007;195(6):521-531.
Bandelow B et al. WFSBP guidelines for the pharmacological treatment of anxiety, OCD, and PTSD (update). World J Biol Psychiatry. 2023.
Glue P et al. Ketamine for refractory generalized and social anxiety: randomized, placebo-controlled crossover trial. J Psychopharmacol. 2018;32(12):1296-1302.
Ross S et al. Psilocybin for anxiety/depression in patients with life-threatening cancer: randomized trial. J Psychopharmacol. 2016;30(12):1165-1180.
Goyal M et al. Meditation programs for psychological stress and well-being: systematic review and meta-analysis. JAMA Intern Med. 2014;174(3):357-368.
Khoury B et al. Mindfulness-based therapy: A comprehensive meta-analysis. Clin Psychol Rev. 2013;33(6):763-771.
Cramer H et al. Yoga for anxiety: a systematic review and meta-analysis of RCTs. Depress Anxiety. 2018;35(9):830-843.
Vollbehr NK et al. Yoga as a treatment for anxiety disorders: systematic review and meta-analysis. J Anxiety Disord. 2018;61:201-214.
Zaccaro A et al. How breath-control can enhance psychophysiological well-being: systematic review. Front Hum Neurosci. 2018;12:353.
Chandrasekhar K et al. Ashwagandha root extract for stress/anxiety: randomized, double-blind, placebo-controlled. Indian J Psychol Med. 2012;34(3):255-262.
Lopresti AL et al. Efficacy and safety of ashwagandha in adults with stress and anxiety: randomized, double-blind, placebo-controlled. Medicine (Baltimore). 2019;98:e17186.
Ng QX et al. Ashwagandha for anxiety and stress: systematic review and meta-analysis. J Altern Complement Med. 2020;26(11):1061-1067.
Darbinyan V et al. Rhodiola rosea in stress-related fatigue with anxiety symptoms: randomized trial. Phytomedicine. 2007;14:87-95.
Cohen MM. Tulsi—Ocimum sanctum: a herb for all reasons. J Ayurveda Integr Med. 2014;5(4):251-259.
Pilkington K et al. Acupuncture for anxiety and anxiety disorders: systematic review. Acupunct Med. 2007;25(1-2):1-10.
Amorim D et al. Acupuncture and electroacupuncture for anxiety disorders: systematic review. Complement Ther Clin Pract. 2018;33:201-207.
Wang YQ et al. Suanzaoren decoction for primary insomnia: meta-analysis of RCTs. Sleep Med. 2020;67:251-260.
NCCIH. Ayurvedic Medicine: In Depth. https://www.nccih.nih.gov/health/ayurvedic-medicine-in-depth

Health Disclaimer